Fundraising Fox
Ultromics
Founded 2017 · 84 employees on LinkedIn · 9 known investors
Find your way into Ultromics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Saeju Jeong to introduce you to Ross Upton
You →Saeju · together at Foundation for the National Institutes of Health →Ross
Sign up to find every way you can get introduced to Ultromics
- Your email: who you already know at Ultromics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ultromics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Ultromics develops AI models that analyze routine echocardiography studies to help clinicians detect HFpEF and screen for cardiac amyloidosis, delivered through a single workflow platform. Its findings integrate into existing PACS, CVIS, and EMR systems via standard DICOM routing for hospitals and echo labs.
Founders & leadership
Ultromics was founded in 2017 by Ross Upton.
Investors · 9
How we know: GV (Google Ventures)'s portfolio page · the company's own site · funding news · Not right? Tell us
How we know: Oxford Science Enterprises's portfolio page · the company's own site · the Companies House PSC register · funding news · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: Future Planet Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: Optum Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Ultromics went on to found or lead other companies.
Companies House · registry record
View on Companies House ↗- Registered name
- ULTROMICS LIMITED
- Company number
- 10684811
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 22 Mar 2017
- Registered office
- 4630 Kingsgate Cascade Way, Oxford Business Park South, Oxford, Oxfordshire, OX4 2SU
- Nature of business (SIC)
- 86900 — Other human health activities
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 13 Dec 2025 · next due 27 Dec 2026
Current officers · 6
- Christopher John Percival Hopkins — director, appointed 17 Apr 2026
- Sakip-Umur Hurserver — director, appointed 27 Jun 2025
- Helen Frances Routh — director, appointed 26 Jan 2018
- Heather Elaine Roxborough — director, appointed 8 Mar 2023
- Emir Singh Sandhu — director, appointed 10 Aug 2021
- Ross Upton — director, appointed 18 May 2017
Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Ultromics do?
- Ultromics develops AI models that analyze routine echocardiography studies to help clinicians detect HFpEF and screen for cardiac amyloidosis, delivered through a single workflow platform. Its findings integrate into existing PACS, CVIS, and EMR systems via standard DICOM routing for hospitals and echo labs.
- Who founded Ultromics?
- Ultromics was founded by Ross Upton in 2017.
- Who are Ultromics's investors?
- Ultromics's investors include GV (Google Ventures), Oxford Science Enterprises, Legal & General, Future Planet Capital, Nina Capital, NovaCapital, Optum Ventures, ALLEGIS CAPITAL and 1 more.